Dawei Chen
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 32
- Lung Cancer Research Studies 16
- Inflammatory Biomarkers in Disease Prognosis 8
- Cancer Cells and Metastasis 5
-
- Lung Cancer Diagnosis and Treatment 22
- Lung Cancer Treatments and Mutations 19
- Immunology top 5%
- Immunotherapy and Immune Responses 11
- Cancer Research top 5%
- Radiation top 5%
-
- Neuroendocrine Tumor Research Advances 6
- Co-authors
- Zengfu ZhangJinming YuXu LiuJames W. WelshVivek VermaHampartsoum B. BarsoumianMaría Angélica CortezRoshal R. Patel
- Journals
- Frontiers in Oncology (6 papers)Frontiers in Immunology (5 papers)International Journal of Radiation Oncology*Biology*Physics (5 papers)
- Partner nations
- ChinaUnited StatesTürkiye
In The Last Decade
Dawei Chen
80 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 933
- Immunology 554
- Cancer Research 323
- Radiation 97
Countries citing papers authored by Dawei Chen
This map shows the geographic impact of Dawei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Chen more than expected).
Fields of papers citing papers by Dawei Chen
This network shows the impact of papers produced by Dawei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Chen. The network helps show where Dawei Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dawei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 3 | |
| 10 | Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCANbreakdown → | 2024 | 55 |
| 11 | 2024 | 1 | |
| 12 | 2024 | 13 | |
| 13 | 2023 | 32 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2022 | 30 | |
| 17 | 2022 | 48 | |
| 18 | 2021 | 52 | |
| 19 | 2020 | 63 | |
| 20 | 2019 | 19 |
About Dawei Chen
Dawei Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Hepatology, having authored 91 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (32 papers), Lung Cancer Diagnosis and Treatment (22 papers), Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (16 papers), Immunotherapy and Immune Responses (11 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Oncology (1.5k citations), Pulmonary and Respiratory Medicine (933 citations), Immunology (554 citations), Cancer Research (323 citations) and Radiation (97 citations). Dawei Chen has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Zengfu Zhang, Jinming Yu, Xu Liu, James W. Welsh, Vivek Verma, Hampartsoum B. Barsoumian, María Angélica Cortez, Roshal R. Patel, Joe Y. Chang and Jinming Yu. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.